Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$319M |
| 2 |
GSK
GSK
|
+$230M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$192M |
| 4 |
Verizon
VZ
|
+$174M |
| 5 |
Mastercard
MA
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$850M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$466M |
| 5 |
Meta Platforms (Facebook)
META
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.58% |
| 2 | Technology | 5.48% |
| 3 | Financials | 4.9% |
| 4 | Energy | 3.61% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRC
6226
CALL
DELISTED
DRESSER-RAND GROUP INC
DRC
| $8K | ﹤0.01% |
100
-38,000
| -100% | -$3.08M |
|
|
PNX
6227
DELISTED
PHOENIX COMPANIES INC. NEW
PNX
| $8K | ﹤0.01% |
173
-2,741
| -94% | -$165K |
|
|
REXX
6228
PUT
DELISTED
Rex Energy Corporation
REXX
| $8K | ﹤0.01% |
260
+170
| +189% | +$6.99K |
|
|
NEWS
6229
DELISTED
NewStar Financial, Inc.
NEWS
| $8K | ﹤0.01% |
798
-723
| -48% | -$7.79K |
|
6230
Axcelis
ACLS
$4.36B
| $7K | ﹤0.01% |
839
-3,670
| -81% | -$37.9K |
|
6231
Alamos Gold
AGI
$12.9B
| $7K | ﹤0.01% |
1,300
| – | – |
|
6232
Alto Ingredients
ALTO
$351M
| $7K | ﹤0.01% |
717
-1,525
| -68% | -$14.7K |
|
6233
American Superconductor
AMSC
$1.62B
| $7K | ﹤0.01% |
1,279
-7,903
| -86% | -$59.2K |
|
6234
Angi Inc
ANGI
$198M
| $7K | ﹤0.01% |
131
-117
| -47% | -$6.91K |
|
|
BFIN
6235
DELISTED
BankFinancial
BFIN
| $7K | ﹤0.01% |
553
-695
| -56% | -$8.3K |
|
|
BGFV
6236
DELISTED
Big 5 Sporting Goods
BGFV
| $7K | ﹤0.01% |
556
-4,695
| -89% | -$60.1K |
|
6237
Pathward Financial
CASH
$1.87B
| $7K | ﹤0.01% |
552
-498
| -47% | -$5.89K |
|
6238
CNB Financial Corp
CCNE
$1.04B
| $7K | ﹤0.01% |
435
-740
| -63% | -$12.8K |
|
6239
Ceco Environmental
CECO
$4.02B
| $7K | ﹤0.01% |
635
-3,408
| -84% | -$46.2K |
|
6240
Coherus Oncology
CHRS
$207M
| $7K | ﹤0.01% |
208
-180
| -46% | -$4.65K |
|
6241
Clarus
CLAR
$130M
| $7K | ﹤0.01% |
694
-8,625
| -93% | -$64.7K |
|
6242
PC Connection
CNXN
$2.17B
| $7K | ﹤0.01% |
289
-262
| -48% | -$6.43K |
|
6243
Cohu
COHU
$2.49B
| $7K | ﹤0.01% |
758
-1,293
| -63% | -$14.6K |
|
6244
Crawford & Co Class B
CRD.B
$559M
| $7K | ﹤0.01% |
839
-1,433
| -63% | -$13.3K |
|
|
CTO
6245
CTO Realty Growth
CTO
$816M
| $7K | ﹤0.01% |
479
-2,627
| -85% | -$40.7K |
|
6246
Culp Inc
CULP
$45.3M
| $7K | ﹤0.01% |
263
-357
| -58% | -$8.07K |
|
6247
Citizens & Northern Corp
CZNC
$451M
| $7K | ﹤0.01% |
369
-340
| -48% | -$6.72K |
|
|
DEA
6248
Easterly Government Properties
DEA
$1.18B
| $7K | ﹤0.01% |
+182
| New | +$7.27K |
|
6249
Enphase Energy
ENPH
$5.25B
| $7K | ﹤0.01% |
553
-4,438
| -89% | -$57.4K |
|
6250
CALL
Energy Recovery
ERII
$443M
| $7K | ﹤0.01% |
+3,500
| New | +$12K |
|
Similar funds
Barclays's Q1 2015 Portfolio in Review
As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.
- Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
- Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
- Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
- Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
- Barclays opened 330 new positions and closed 488 in Q1 2015.
- Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.